A Drug Stock, a Rebalance, and a Record Quarter: The Story Behind VanEck’s Dividend ETF
11.06.2026 - 13:52:11 | boerse-global.de
Pfizer is not the largest holding in the VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF — that title belongs to Verizon Communications at 4.64% — but the pharmaceutical group has suddenly become one of the most talked-about names in the portfolio. On 10 June, two headlines hit simultaneously: RBC Capital lifted its rating on the drugmaker from “Underperform” to “Sector Perform,” setting a $25 price target, while Pfizer’s chief executive warned that German price?control proposals for medicines could delay or curtail planned investments in the country.
At 3.52% of the fund’s assets, Pfizer is one of ten positions that together account for roughly 35% of the ETF. Its presence alongside Roche gives healthcare a meaningful slice of a portfolio otherwise dominated by financials (31%) and energy (20%). The Pfizer news, however, remains an isolated data point for now. The ETF’s net asset value settled at €51.90 on 10 June, putting it about seven percent higher year?to?date and roughly 22% above its level twelve months ago. The 50?day moving average sits at €52.42, a whisker above the current price, while the 200?day average of €48.94 shows plenty of room underneath. The relative strength index of 43.5 suggests neither froth nor panic.
Those figures come on the heels of a bruising week for growth stocks that barely registered on TDIV. When the Nasdaq tumbled more than four percent last Friday after a red?hot US jobs report, the dividend fund lost just 0.17%. At €52.33, it now trades about 0.83% above its previous close and some seven percent above its 200?day average. Annualised performance over five years stands at 17.9%, handily beating its category index (15.4%) and the peer?group average (8.3%). Morningstar awards it five stars.
The secret to that defensive resilience lies partly in the portfolio’s sector tilt. With the ECB deposit rate at 2.0% and euro?zone inflation running at 3.0%, financials and energy — which together make up more than half the fund — enjoy a tailwind that many tech?heavy strategies lack. The semi?annual rebalancing earlier in the spring trimmed Exxon Mobil back below the 5% single?name cap after its weighting had ballooned to 5.69%, redistributing the excess across other dividend payers in the index.
That discipline has not hurt asset gathering. A year ago TDIV managed roughly €1.2 billion; today it sits at about €7.8 billion. In the first quarter of 2026 alone, net inflows reached €2.1 billion — more than any other European dividend ETF captured in the same period. Globally, dividend?oriented funds pulled in $24 billion during the quarter, the strongest three?month haul in four years. The explanation analysts offer is that Big Tech is channelling free cash flow into artificial?intelligence capex rather than buybacks, pushing yield?hungry investors toward alternatives.
Costs help too. TDIV’s ongoing charge of 0.38% undercuts the category average of 1.06% by a wide margin, though Vanguard’s FTSE All?World High Dividend Yield UCITS ETF charges even less at 0.29% and manages a slightly larger €8.3 billion. On a one?year performance basis through May, the Xtrackers STOXX Global Select Dividend 100 Swap ETF leads the pack at 30.4%, followed by TDIV and then Vanguard at 24.5%.
VanEck has also expanded its dividend lineup. On 23 April it launched TDVX, a sister ETF that follows the same index methodology but excludes US stocks. Listed in London and Frankfurt, TDVX offers an accumulating share class — something the Dutch?domiciled TDIV cannot provide, as its structure only permits distributing shares. The Börse Düsseldorf recently named TDIV “ETF of the month,” and the appointment of ICF Bank as designated sponsor on the Düsseldorf platform promises tighter bid?ask spreads from 9 a.m. to 5:30 p.m. daily, a concrete benefit for retail investors.
The next major test for TDIV comes soon. US inflation data and the Federal Reserve meeting in the coming week will determine whether rising yield expectations squeeze the dividend premium once again — or whether the fund can weather that macro test as calmly as it did the growth?stock rout of early June.
Ad
VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF Stock: New Analysis - 11 June
Fresh VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Read our updated VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF analysis...
